"The plan is to open a waiting list system, but at the moment we are still in the evaluation process with Bio Farma," said deputy chairperson of Kadin, Shinta Widjaja Kamdani, during a dialogue on ‘Indonesia's Readiness and Preparedness with Gotong Royong Vaccines’, originating from Jakarta on Wednesday.
A waiting list is being considered for companies that are looking to participate in Gotong Royong vaccinations given the high demand and relatively limited supply of vaccines provided by the government, she elaborated.
So far, at least 28 thousand companies with 10.5 million employees have registered with Kadin for the Gotong Royong vaccination program, she said.
However, just 500 thousand doses of the Sinopharm vaccine have been received as part of the first phase of the vaccine allocations, she revealed.
"This amount must also be divided again with State-Owned Enterprises (SOE) employees, so private companies can only get 300 thousand doses," she said.
As per the government’s directions, priority will be given to participants from the manufacturing sector in the Greater Jakarta area in vaccine allocations, she added. "However, the number of vaccines cannot match that of companies' requests. The allocation for companies is being done in stages," she said, adding that it could be challenging to adapt to the volume of supply.
The paid vaccination program is open to all companies, including foreign capital companies (PMA), domestic investment companies (PMDN), and micro, small, and medium enterprises (MSMEs), Kamdani said.
"But this is not mandatory, so all Indonesians can get free vaccines from the government. If there are companies that are severely affected by COVID-19 and cannot participate in the Gotong Royong vaccination, please join the free vaccination program," she added. (INE)
EDITED BY INE